Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VT✓SelectedUSD · VTGSK vs VT performance historyLatest closeAs of+2.40%11/09
Stock and ETF performance explorer

GSK vs VT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+100.5%
VT return
+223.7%
Excess return
-123.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioVTExcessAlpha
1D+2.4%+2.6%-0.2%+1.0%
7D+4.9%+0.4%+4.5%+4.7%
30D+10.8%-2.6%+13.4%+12.3%
3M-1.8%-3.2%+1.4%-0.2%
6M+4.1%+0.9%+3.2%+3.1%
YTD+7.9%+11.3%-3.4%+1.2%
1Y+14.4%+14.0%+0.4%+5.9%
3Y+68.1%+75.8%-7.7%+20.6%
5Y+47.7%+57.8%-10.2%+11.8%
10Y+100.5%+219.8%-119.3%-6.9%
All+100.5%+223.7%-123.2%-6.9%

Cumulative growth

Daily Returns

Daily percentage return beside VT.

Daily Out/Under-Performance

Portfolio return minus VT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded VT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling